Michael A. Metzger
2016
In 2016, Michael A. Metzger earned a total compensation of $731.9K as Chief Operating Officer at Syndax Pharmaceuticals, a 76% decrease compared to previous year.
Compensation breakdown
| Bonus | $40,000 |
|---|---|
| Non-Equity Incentive Plan | $218,500 |
| Salary | $470,360 |
| Other | $3,000 |
| Total | $731,860 |
Metzger received $470.4K in salary, accounting for 64% of the total pay in 2016.
Metzger also received $40K in bonus, $218.5K in non-equity incentive plan and $3K in other compensation.
Rankings
In 2016, Michael A. Metzger's compensation ranked 9,691st out of 14,075 executives tracked by ExecPay. In other words, Metzger earned more than 31.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,691 out of 14,075 | 31st |
Division Manufacturing | 3,753 out of 5,486 | 32nd |
Major group Chemicals And Allied Products | 1,307 out of 1,900 | 31st |
Industry group Drugs | 1,040 out of 1,543 | 33rd |
Industry Pharmaceutical Preparations | 816 out of 1,173 | 30th |
Source: SEC filing on April 10, 2018.
Metzger's colleagues
We found two more compensation records of executives who worked with Michael A. Metzger at Syndax Pharmaceuticals in 2016.
News
Syndax Pharmaceuticals CEO Briggs Morrison's 2021 pay jumps 80% to $3.9M
March 29, 2022
Syndax Pharmaceuticals CFO Daphne Karydas receives $3.1M in 2020
April 1, 2021
Syndax Pharmaceuticals COO Michael Metzger's 2019 pay jumps 77% to $2.7M
April 29, 2020
Syndax Pharmaceuticals CEO Briggs Morrison's 2018 pay jumps 24% to $2.1M
April 30, 2019